好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Fall Conference | C9 - Clinical Pearls in Autoimmune Neurology: Real-world Cases

Friday 11/07/25
03:00 PM - 04:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Sarosh R. Irani, MD, PhD, FRCP, FEAN
Autoimmune Neurology
Participants should be able to recognize and become familiar with case-based descriptions of some of neurology's most treatable autoimmune conditions, spanning the breadth of demyelination, encephalitis, and peripheral neuropathies; recall and interpret investigation features which lead to, and divert from, an accurate autoimmune diagnosis including conditions with antibodies against AQP4, MOG, GAD, LGI1, CASPR2, Iglon5, and NF-155 and formulate, appraise, and synthesize management plans for these patients
1.50 CME credits

Program Materials Program Evaluations

Event Timeline
03:00 PM - 03:45 PM PDT Speaker Clinical Pearls in Autoimmune Neurology: Real-world Cases
Sarosh R. Irani, MD, PhD, FRCP, FEAN
03:45 PM - 04:30 PM PDT Speaker Confusing Cases from the Brain and Cord
Max Herman, MD
Faculty Disclosures
Sarosh R. Irani, MD, PhD, FRCP, FEAN Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Argenex, Atheneum, AZ, Clarivate, IQVIA, BioHaven therapeutics. Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion US, Amgen, Argenx . Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. The institution of Dr. Irani has received research support from Amgen. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Max Herman, MD Dr. Herman has nothing to disclose.